• Skip to Content
  • Skip to Sidebar
IU

Indiana University Bloomington Indiana University Bloomington IU Bloomington

Menu

ScIUConversations in Science at Indiana University

  • Home
  • Home
  • About ScIU
  • Write with Us!
  • Contact ScIU
  • The Writers and Editors of ScIU
  • ScIU in the Classroom
  • Annual Science Communication Symposium
  • Search

IU’s take on the cannabis trend

Posted on April 18, 2020 by Riddhi Sood

On March 20, 2019, Department of Psychological and Brain Sciences Professor Emeritus Dr. Brian O’Donnell and Research Scientist Dr. Alex Straiker met with the student community for a Q&A session entitled “Cannabis: Science and Policy.”

“IU has been the world center for research regarding cannabinoid signaling,” said Dr. Straiker during his address at the Science Café talk. Having studied cannabinoid signaling for more than 20 years, Dr. Straiker mentions the growing enthusiasm for cannabis use in a variety of forms, like essential oils; not only recreationally, but also for the treatment of anxiety, autoimmune disease, inflammation, and pain management.

Dr. Straiker’s introduction to cannabinoid signaling started as a curiosity when an acquaintance mentioned cannabis’s effects. This curiosity led to him pitching cannabis as a potential project to his Ph.D. advisor, and he has never looked back. Dr. O’Donnell’s introduction to cannabis-related research started 12 years ago, when a postdoctoral scholar wondered if there was a connection between the cannabinoid system and psychotic disorders like schizophrenia.

So, when IU’s undergraduate-lead neuroscience club wanted to educate other students about the science of cannabis use, they didn’t have to look further than their own department!

The image shows Cannabis sativa plant.
Cannabis sativa plant. Image credit: NickyPe (Pixabay: https://pixabay.com/photos/hemp-cannabis-sativa-nature-crop-4354389/).

Although cannabis is legal to use medically in 33 states and recreationally in 10 states in the U.S., scientific research on cannabis use has been challenging. “In human studies, given that cannabis and derived compounds are schedule one substances,” says Dr. O’Donnell, “it’s extremely difficult to do human studies using specific compounds, or even to have a person smoke marijuana in lab. So, our ability to do that is very limited.”

The issues don’t stop there, as the lack of research on cannabinoids is a public health issue due to increased availability of cannabis products. With the presence of synthetic cannabinoid substances out there, “some people are dying, and they’re having psychotic effects. They’re having long-term heart damage. It’s just really bad news,” says Dr. Straiker. When these substances came on the scene (around 2008 in the U.S.), there was barely any research into their effects. But Dr. Straiker, who was then a first year Ph.D. student, jumped to the challenge and provided neurological pharmacology analysis.

While Dr. Straiker works to see how cannabinoid substances affect our bodies molecularly, Dr. O’Donnell works directly with humans, comparing cannabis users to non-users and determining their lifetime exposures to cannabis on a series of measures, including cognitive skills and psychological well-being.

“It’s now been replicated in a number of different countries that cannabis use, in early adolescence in particular, increases the risk of psychotic disorders like schizophrenia later in life,” says Dr. O’Donnell. “So even in people who are clinically ill, they still show an elevation, and these kind of odd thoughts [like] strange or distorted perception may be related to cannabis use.” One of the questions that still confounds him is whether this relationship is causal or simply an association: does marijuana use early in life heighten the risk of later psychological problems? Without an ability to study the schedule one drug in a controlled, large-scale manner, however, scientists are far from answering that question.  

Since research is still years behind from definitively saying what the true risks for the use of cannabinoids are, a question may come to mind — why is cannabis legalized?

As an example, Dr. Straiker explained the story of legalization for the use of a type of cannabis — CBD. CBD was approved by the FDA in 2018 as a form of treatment for childhood epilepsy. “[Parents of kids with childhood epilepsy have] been very politically active, and it’s hard to say no to them,” says Dr. Straiker. CBD has no euphoric effects, but it does affect one’s psychological activity. “You might say that they are not getting high,” says Dr. Straiker, “so, you know, what’s the rationale for saying no under those circumstances?”

When asked how policies on cannabis use have changed from when they first started working in this field, their responses were variations of “never thought this would happen.” So, I will leave you to come to your own conclusions about this complex saga of cannabis research and use.

Edited by Lana Ruck and Clara Boothby

Print Friendly, PDF & Email

Related

Filed under: Current Events, Cutting-Edge Science at IU, General Science, Spotlight on PeopleTagged #scicomm, #ScienceMatters, cannabinoids, cannabis, psychology, science policy

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Additional Content

Search ScIU

Categories

Tag cloud

#Education #scicomm animal behavior anthropology archaeology astronomy astrophysics Biology biotechnology Black History Month brain cannabinoids cannabis Chemistry climate change conservation coronavirus COVID–19 Diversity in Science diversity in STEM Ecology environment evolution geology history and philosophy of science infectious disease Interdisciplinary Interview Mental Health methods microbiology neuroscience outreach physics Plants primates psychology Research science communication science education Science Outreach science policy Statistics STEM women in STEM

Subscribe

Receive a weekly email with our new content! We will not share or use your information for any other purposes, and you may opt out at any time.

Please, insert a valid email.

Thank you, your email will be added to the mailing list once you click on the link in the confirmation email.

Spam protection has stopped this request. Please contact site owner for help.

This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Current Contributors

  • Log in
  • SPLAT
  • ScIU Guides

Indiana University

Copyright © 2022 The Trustees of Indiana University | Privacy Notice | Accessibility Help

  • Home
  • About ScIU
  • Write with Us!
  • Contact ScIU
  • The Writers and Editors of ScIU
  • ScIU in the Classroom
  • Annual Science Communication Symposium
College of Arts + Sciences

Are you a graduate student at IUB? Would you like to write for ScIU? Email sciucomm@iu.edu


Subscribe

Subscribe By Email

Get every new post delivered right to your inbox.

This form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Loading Comments...